Accessibility Menu
Arrow-Thin-Down
S&P 500
6,840.20
+0.3%
+17.86
Arrow-Thin-Down
DJI
47,562.87
+0.1%
+40.75
Arrow-Thin-Down
NASDAQ
23,724.96
+0.6%
+143.81
Arrow-Thin-Down
Bitcoin
$110,314.00
+0.9%
+$1,005.39
Arrow-Thin-Down
AAPL
$270.57
-0.3%
-$0.83
Arrow-Thin-Down
AMZN
$244.64
+9.8%
+$21.78
Arrow-Thin-Down
GOOG
$281.90
0.0%
$0.00
Arrow-Thin-Down
META
$649.04
-2.6%
-$17.43
Arrow-Thin-Down
MSFT
$518.14
-1.4%
-$7.62
Arrow-Thin-Down
NVDA
$202.80
-0.0%
-$0.09
Arrow-Thin-Down
TSLA
$456.60
+3.7%
+$16.50
Daily Stock GainersDaily Stock LosersMost Active Stocks
Novozymes A/s Stock Quote

Novozymes A/s (OTC: NVZM.Y)

$59.68
(-1.1%)
-0.69
Price as of October 31, 2025, 3:59 p.m. ET

KEY DATA POINTS

Current Price
$59.68
Daily Change
(-1.1%) $0.69
Day's Range
$59.33 - $59.97
Previous Close
$59.68
Open
$59.74
Beta
0.49
Volume
37,189
Average Volume
39,321
Sector
Materials
Market Cap
24.6B
Market Cap / Employee
$59.68M
52wk Range
$53.95 - $75.99
Revenue
-
Gross Margin
0.47%
Dividend Yield
1.62%
EPS
$0.71
CAPs Rating
-
Industry
Chemicals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Novozymes A/s Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
NVZM.Y-3.38%+7.58%+1.47%+1,629%
S&P+19.89%+109.18%+15.89%+722%

Novozymes A/s Company Info

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.

News & Analysis

Featured Article

Investing in Agriculture Stocks

Jeremy Bowman  |  Oct 28, 2025

Financial Health

General

Q2 2025YOY Change
Revenue$1.16B0.0%
Gross Profit$617.64M0.0%
Gross Margin53.46%0.0%
Market Cap$29.55B0.0%
Market Cap / Employee$4.37M0.0%
Employees6.8K0.0%
Net Income$155.18M0.0%
EBITDA$398.49M0.0%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$385.26M0.0%
Accounts Receivable$841.77M0.0%
Inventory938.60.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$3.49B0.0%
Short Term Debt$407.33M0.0%

Ratios

Q4 2023YOY Change
Return On Assets10.63%0.0%
Return On Invested Capital15.43%0.0%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$271.22M0.0%
Operating Free Cash Flow$351.75M0.0%

Valuation

MetricQ4 2023YoY Change
Price to Earnings34.70-
Price to Book7.402.082.75-
Price to Sales5.87-
Price to Tangible Book Value8.7020.2020.21-
Enterprise Value to EBITDA75.5566.0592.19-
Return on Equity21.6%-
Total Debt$1.15B$1.84B$3.90B-

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services